COMMUNIQUÉS West-GlobeNewswire

-
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
24/10/2024 -
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
24/10/2024 -
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
24/10/2024 -
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
24/10/2024 -
Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week
24/10/2024 -
Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024
24/10/2024 -
Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies
24/10/2024 -
INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination
24/10/2024 -
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
24/10/2024 -
Un chirurgien saoudien récompensé pour avoir réalisé la première transplantation cardiaque robotisée au monde
24/10/2024 -
Inozyme Pharma Announces Positive Interim Data from Phase 1 SEAPORT 1 Trial of INZ-701
24/10/2024 -
Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule
24/10/2024 -
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push
24/10/2024 -
Raw Garden Launches Live Resin Sauce Cartridges: Award-Winning Live Resin in a Convenient Ceramic Cartridge
24/10/2024 -
ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2024
24/10/2024 -
Eurobio Scientific : ouverture de l’offre publique d’achat jusqu’au 27 novembre
24/10/2024 -
GUERBET : Chiffre d’affaires au 30 septembre 2024.
24/10/2024 -
GUERBET : Revenue at September 30, 2024.
24/10/2024 -
ONWARD® Medical Publishes Prospectus for Listing of New Shares
24/10/2024
Pages